Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2018

Phase 1b-2 Results of a Novel Targeted Therapy for Treatment of Choroidal Melanoma

Show Description +

In this video, Amy C. Schefler, MD, FACS, provides highlights from her ASRS talk on the 6-month results of a prospective, multicenter clinical trial of intravitreal AU-011 (Aura Biosciences) in the treatment of patients with choroidal melanoma.

Posted: 7/20/2018

Up Next

The ASRS Takes Vancouver

Timothy G. Murray, MD, MBA

A Role for Biosimilars in Retina?

Alay S. Banker, MD, Charles C. Wykoff, MD, PhD, FACS

OCT-A in Pediatric Patients

Lejla Vajzovic, MD

Key Points From the Phase 3 PANORAMA Study

Charles C. Wykoff, MD, PhD, FACS

The Future of Global Trends in Retina

Ehab N. El Rayes, MD, PhD, Paul Hahn, MD, PhD

How Has the Value of Retinal Procedures Changed?

Pravin U. Dugel, MD, Timothy G. Murray, MD, MBA

Here's the DRIL

Amy Babiuch, MD

Women in Retina

Anne E. Fung, MD, Jennifer I. Lim, MD, Nancy M. Holekamp, MD

Surgical Repair of Macular Holes

Raymond Iezzi, MD, MS

Phase 1b-2 Results of a Novel Targeted Therapy for Treatment of Choroidal Melanoma

In this video, Amy C. Schefler, MD, FACS, provides highlights from her ASRS talk on the 6-month results of a prospective, multicenter clinical trial of intravitreal AU-011 (Aura Biosciences) in the treatment of patients with choroidal melanoma.

Posted: 7/20/2018


Please log in to leave a comment.